These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 26419092)

  • 1. [Death after the intake of amphetamine/ecstasy: two case reports].
    Wöllner K; Stockhausen S; Mußhoff F; Madea B
    Arch Kriminol; 2015; 235(1-2):53-61. PubMed ID: 26419092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute liver failure following the use of ecstasy (MDMA)].
    Lange-Brock N; Berg T; Müller AR; Fliege H; Neuhaus P; Wiedenmann B; Klapp BF; Mönnikes H
    Z Gastroenterol; 2002 Aug; 40(8):581-6. PubMed ID: 12297982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: mechanisms and management of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxications.
    Jones AL; Simpson KJ
    Aliment Pharmacol Ther; 1999 Feb; 13(2):129-33. PubMed ID: 10102941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ecstasy induced acute hepatic failure. Case reports.
    Atayan Y; Çağın YF; Erdoğan MA; Harputluoglu MM; Bilgic Y
    Acta Gastroenterol Belg; 2015; 78(1):53-5. PubMed ID: 26118578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute liver damage after using ecstasy].
    Shiloach E; Zecler E; Horowiz M; Scapa E
    Harefuah; 1998 Feb; 134(4):266-9, 335. PubMed ID: 10909502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fatal case of myocardial damage due to misuse of the "designer drug" MDMA.
    Sano R; Hasuike T; Nakano M; Kominato Y; Itoh H
    Leg Med (Tokyo); 2009 Nov; 11(6):294-7. PubMed ID: 19828353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ecstasy--the status in French-speaking Switzerland. Composition of seized drugs, analysis of biological specimens and short review of its pharmacological action and toxicity].
    Giroud C; Augsburger M; Sadeghipour F; Varesio E; Veuthey JL; Rivier L
    Praxis (Bern 1994); 1997 Mar; 86(13):510-23. PubMed ID: 9157497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of acute psychotic episode after a single dose of ecstasy].
    Vaiva G; Bailly D; Boss V; Thomas P; Lestavel P; Goudemand M
    Encephale; 2001; 27(2):198-202. PubMed ID: 11407274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylenedioxymethamphetamine (ecstasy)-related myocardial hypertrophy: an autopsy study.
    Patel MM; Belson MG; Wright D; Lu H; Heninger M; Miller MA
    Resuscitation; 2005 Aug; 66(2):197-202. PubMed ID: 15963623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
    Parrott AC
    J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute giant cell hepatitis in a 17-year old man].
    Muñoz P; Drobinska A; Bianchi L; Züger Ch; Pirovino M
    Praxis (Bern 1994); 2004 Dec; 93(50):2109-12. PubMed ID: 15646679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-mortem cases involving amphetamine-based drugs in The Netherlands. Comparison with driving under the influence cases.
    Verschraagen M; Maes A; Ruiter B; Bosman IJ; Smink BE; Lusthof KJ
    Forensic Sci Int; 2007 Aug; 170(2-3):163-70. PubMed ID: 17658708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphetamines as potential inducers of fatalities: a review in the district of Ghent from 1976-2004.
    De Letter EA; Piette MH; Lambert WE; Cordonnier JA
    Med Sci Law; 2006 Jan; 46(1):37-65. PubMed ID: 16454462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans.
    Huxster JK; Pirona A; Morgan MJ
    J Psychopharmacol; 2006 Mar; 20(2):281-90. PubMed ID: 16510486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does hyperthyroidism increase risk of death due to the ingestion of ecstasy?
    Martin TL; Chiasson DA; Kish SJ
    J Forensic Sci; 2007 Jul; 52(4):951-3. PubMed ID: 17524054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ecstasy ingestion and fulminant hepatic failure: liver transplantation to be considered as a last therapeutic option.
    Garbino J; Henry JA; Mentha G; Romand JA
    Vet Hum Toxicol; 2001 Apr; 43(2):99-102. PubMed ID: 11308131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic exposure to ethanol exacerbates MDMA-induced hyperthermia and exposes liver to severe MDMA-induced toxicity in CD1 mice.
    Pontes H; Duarte JA; de Pinho PG; Soares ME; Fernandes E; Dinis-Oliveira RJ; Sousa C; Silva R; Carmo H; Casal S; Remião F; Carvalho F; Bastos ML
    Toxicology; 2008 Oct; 252(1-3):64-71. PubMed ID: 18761051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of amphetamine-type stimulant mortality data--UK, 1997-2007.
    Schifano F; Corkery J; Naidoo V; Oyefeso A; Ghodse H
    Neuropsychobiology; 2010; 61(3):122-30. PubMed ID: 20110737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute hepatitis due to ingestion of Ecstasy].
    Huarte Muniesa MP; Pueyo Royo AM
    Rev Esp Enferm Dig; 1995 Sep; 87(9):681-3. PubMed ID: 7577130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. False-positive amphetamine/ecstasy (MDMA/3,4-methylenedioxymethamphetamine) (CEDIA) and ecstasy (MDMA/3,4-methylenedioxymethamphetamine) (DRI) test results with fenofibrate.
    Kaplan YC; Erol A; Karadaş B
    Ther Drug Monit; 2012 Oct; 34(5):493-5. PubMed ID: 22972534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.